Luis Ignacio Casanova Peño, et al. “Clinical Data Associated With the Therapeutic Response to Glatiramer Acetate in Multiple Sclerosis Patients”. Neuro, vol. 3, no. 1, Sept. 2016, pp. 3-8, doi:10.17140/NOJ-3-121.